Routine lipid panel
+ reported LDL-C
Review the source information available and how close the result is to the goal.
FIRST APPLICATION / LDL CHOLESTEROL
A result near the goal.
Evidence worth
a closer look.
AN ILLUSTRATIVE LIPID PANEL
Total cholesterol150HDL-C45Triglycerides180
All values in mg/dLReported LDL-C69 mg/dL
Documented goal<70 mg/dL
GOVERN note: the available evidence does not consistently support the below-goal conclusion. The reported value is unchanged, and the clinician decides what follows.
THE LDL-C WORKFLOW
When does another
measurement add value?
A reported LDL-C is derived from the same lipid inputs. A separately performed assay uses a different analytical method—but different does not automatically mean more accurate.
Routine lipid panel
A separately performed
direct LDL-C assay
Record a separate method result beside the reported value and show its source clearly.
Beta-quantification
(BQ)
Compare threshold classifications while keeping the reference result distinct from source origin.
This comparison supports evidence review. It does not recommend additional testing or make a clinical decision.
A BOUNDED STARTING POINT
A laboratory claim.
Not a treatment decision.
One defined threshold
GOVERN’s first application assesses evidence for an LDL-C classification below 70 mg/dL. It does not assign an individual patient’s treatment goal.
Institution-controlled workflow
Pilot scope is agreed with the institution. GOVERN does not change laboratory results, order clinical tests, or authorize treatment or payer actions.
Evidence boundary
GOVERN keeps numerical estimates, source information, and independent reference comparisons distinct. It does not make treatment or testing decisions.
PRODUCT PILOT PARTNERSHIPS
Turn a workflow question
into a focused pilot.
Explore measurement-integrity and source-review workflows with your team.
Discuss a clinical pilot Start with a conversation. No patient data required.